UBS Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.67M | Buy |
177,910
+111,097
| +166% | +$5.41M | ﹤0.01% | 2544 |
|
|
2025
Q1 | $1.44M | Buy |
66,813
+19,942
| +43% | +$430K | ﹤0.01% | 3930 |
|
|
2024
Q4 | $1.26M | Buy |
46,871
+40,994
| +698% | +$1.1M | ﹤0.01% | 4067 |
|
|
2024
Q3 | $63.2K | Buy |
5,877
+4,410
| +301% | +$47.4K | ﹤0.01% | 5471 |
|
|
2024
Q2 | $17.5K | Buy |
1,467
+1,232
| +524% | +$14.7K | ﹤0.01% | 6238 |
|
|
2024
Q1 | $4.32K | Buy |
+235
| New | +$4.32K | ﹤0.01% | 6465 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 9247 |
|
|
2022
Q2 | $0 | Sell |
1
-85
| -99% | – | ﹤0.01% | 9281 |
|
|
2022
Q1 | $1K | Buy |
86
+85
| +8,500% | +$988 | ﹤0.01% | 8789 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 9120 |
|
|
2021
Q3 | $0 | Sell |
1
-299
| -100% | – | ﹤0.01% | 8386 |
|
|
2021
Q2 | $12K | Sell |
300
-856
| -74% | -$34.2K | ﹤0.01% | 6770 |
|
|
2021
Q1 | $62K | Sell |
1,156
-96
| -8% | -$5.15K | ﹤0.01% | 5337 |
|
|
2020
Q4 | $50K | Sell |
1,252
-6,460
| -84% | -$258K | ﹤0.01% | 5187 |
|
|
2020
Q3 | $440K | Buy |
7,712
+658
| +9% | +$37.5K | ﹤0.01% | 3520 |
|
|
2020
Q2 | $520K | Buy |
7,054
+5,312
| +305% | +$392K | ﹤0.01% | 3349 |
|
|
2020
Q1 | $87K | Buy |
1,742
+1,610
| +1,220% | +$80.4K | ﹤0.01% | 4544 |
|
|
2019
Q4 | $10K | Sell |
132
-321
| -71% | -$24.3K | ﹤0.01% | 6199 |
|
|
2019
Q3 | $18K | Buy |
453
+17
| +4% | +$675 | ﹤0.01% | 5831 |
|
|
2019
Q2 | $14K | Sell |
436
-108
| -20% | -$3.47K | ﹤0.01% | 5960 |
|
|
2019
Q1 | $29K | Buy |
544
+72
| +15% | +$3.84K | ﹤0.01% | 5145 |
|
|
2018
Q4 | $22K | Buy |
472
+240
| +103% | +$11.2K | ﹤0.01% | 5773 |
|
|
2018
Q3 | $20K | Sell |
232
-130
| -36% | -$11.2K | ﹤0.01% | 5871 |
|
|
2018
Q2 | $38K | Buy |
362
+168
| +87% | +$17.6K | ﹤0.01% | 5302 |
|
|
2018
Q1 | $15K | Buy |
194
+124
| +177% | +$9.59K | ﹤0.01% | 5729 |
|
|
2017
Q4 | $10K | Buy |
+70
| New | +$10K | ﹤0.01% | 6031 |
|
|
2017
Q3 | – | Sell |
-7
| Closed | -$1K | – | 6771 |
|
|
2017
Q2 | $1K | Sell |
7
-59
| -89% | -$8.43K | ﹤0.01% | 6524 |
|
|
2017
Q1 | $10K | Sell |
66
-290
| -81% | -$43.9K | ﹤0.01% | 5673 |
|
|
2016
Q4 | $74K | Buy |
356
+223
| +168% | +$46.4K | ﹤0.01% | 4619 |
|
|
2016
Q3 | $31K | Buy |
+133
| New | +$31K | ﹤0.01% | 5015 |
|
|
2015
Q4 | – | Sell |
-49
| Closed | -$12K | – | 6868 |
|
|
2015
Q3 | $12K | Buy |
49
+48
| +4,800% | +$11.8K | ﹤0.01% | 5810 |
|
|
2015
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6768 |
|